Mani Mohindru, CFO & Chief Strategy Officer at Cara Therapeutics, Inc. (CARA), sold 32,082 shares at $19.12 ($613K) on 2019-03-13, disclosed to the SEC on 2019-03-15.
Open-market sale of $613k CARA by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.12 | 16,041 | $307K | 50.0% |
| 2 | $19.12 | 16,041 | $307K | 50.0% |
| Total | $19.12 avg | 32,082 | $613K | 100% |
| Filing → |
| CARA | SELL | 2019-12-04 | $162K | — | Filing → |
| CARA | SELL | 2019-07-17 | $936K | — | Filing → |
| CARA | SELL | 2019-05-30 | $107K | — | Filing → |